David+Vetter+%28bubble+boy%29+from+AP.jpg
“We need to be bold, we think it’s important to be bold for these kids who need this therapy.”
— Mustang Bio, Chief Executive Officer Manny Litchman -- bloomberg.com

“Shares of the tiny biotechnology company Mustang Bio Inc. more than tripled Thursday, following a scientific breakthrough that cured eight infants suffering from the devastating “Bubble Boy” immune system disorder.”

Fantastic development in gene therapy for a rare but, well known disease. Cool company. Well done, MustangBio team!

Read full article in Bloomberg HERE